Filing Details
- Accession Number:
- 0001127602-20-030840
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-08 16:23:38
- Reporting Period:
- 2020-12-04
- Accepted Time:
- 2020-12-08 16:23:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1674278 | D. William Humphries | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | President, Ortho-Dermatologics | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Acquisiton | 2020-12-04 | 114,055 | $14.38 | 349,090 | No | 4 | M | Direct | |
Common Shares, No Par Value | Disposition | 2020-12-04 | 114,055 | $19.87 | 235,035 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares, No Par Value | Non-qualified Stock Options (right To Purchase) | Disposition | 2020-12-04 | 114,055 | $0.00 | 114,055 | $14.38 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2027-03-01 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.80 to $19.82 per share. The Reporting Person will provide to the Commission, the Issuer and any stockholder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range provided in this footnote.
- The options vest in equal installments on each of the first three anniversaries of the date of grant.